MSD Fined €39m In Spain Over Blocking Nuvaring Rival

Insud Pharma’s Ornibel Version Suffered Following Originator Abuse Of Dominant Position

Oct 26 2022

• By David Wallace

The CNMC has fined MSD €39m for abuse of dominant position • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin